While starting with lower doses of GIP/GLP-1 medications such as Mounjaro® and Wegovy®, you may still experience feelings of hunger, especially if you have previously used weight loss medication.
These treatments are started at a lower dose to help minimise side effects and allow your body to adjust to the medication. As your dose gradually increases, you may notice a greater reduction in hunger and appetite. For some people, the appetite-suppressing effects become more noticeable as they move towards their maintenance dose.
It is important to remember that the aim of treatment is appetite control, not the complete absence of hunger or eating. You should still be able to eat regular, balanced meals while taking these medications.
If you find that you are unable to eat or are struggling to keep food or fluids down, please contact us so our clinical team can review your treatment.
For the best results alongside GIP/GLP-1 treatment, aim for a balanced diet that includes nutritious whole foods, such as sources of protein, healthy fats and high-fibre carbohydrates.
Combining your medication with sustainable changes to your diet and physical activity can help you manage your appetite and support your weight management goals.